Keyphrases
Anti-CTLA-4
13%
Anti-tumor Response
13%
Antitumor Activity
13%
Antitumor Agents
13%
Breast Cancer
83%
Cancer Cells
41%
Cancer Patients
13%
Cancer Treatment
13%
Cell Autophagy
13%
Cell Surface
13%
Cell Toxicity
13%
Cellular Mechanisms
13%
Chemotherapy
13%
Clinical Progress
13%
Cyclic Peptide
13%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
13%
Heat Shock Protein 90 (Hsp90)
83%
Heat Shock Protein 90 Inhibitor
27%
Heat Shock Response
13%
Immune Cells
13%
Immune Checkpoint Therapy
27%
Immune System
27%
Immune Tolerance
83%
Immunogenic Cell Death
13%
Innovative Approach
13%
Novel Mechanism of Action
13%
Novel Therapeutics
83%
Potential Impact
13%
Programmed Death-ligand 1 (PD-L1)
27%
Protein Level
13%
Small Molecules
13%
Surface Exposure
16%
Survival Mechanism
13%
Syngeneic Mouse Model
13%
System Recognition
13%
T Cell Immune Response
13%
Tumor
13%
Tumor Cells
13%
Tumor Eradication
13%
Tumor Microenvironment
13%
Tumor-immune System
13%
Immunology and Microbiology
Adoptive Immunity
12%
Antineoplastic Activity
12%
Autophagy
12%
Cancer Cell
49%
Cell Death
26%
Cell Surface
12%
CTLA-4
24%
Cytotoxicity
12%
Heat Shock
100%
Heat Shock Response
12%
Immune Checkpoint Blockade
24%
Immune System
18%
Immune System
8%
Immune Tolerance
100%
Immunocompetent Cell
14%
Immunotherapy
36%
Mediator
12%
Mouse
8%
Mouse Model
12%
Syngenic
12%
T Cell
12%
Tumor Cell
12%